Nigrocin-PN [C15,21L]

General Information


DRACP ID  DRACP04393

Peptide Name   Nigrocin-PN [C15,21L]

Sequence  GLLGKILGAGKKVLLGVSGLL

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C94H172N24O23

Absent amino acids  CDEFHMNPQRTWY

Common amino acids  L

Mass  236350

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  11

Net charge  3

Boman Index  3484

Hydrophobicity  125.71

Aliphatic Index  180.95

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  A novel antimicrobial peptide found in聽Pelophylax nigromaculatus

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19285

DRACP is developed by Dr.Zheng's team.